MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison.
Zhiwen ZhangYan ChenZiqiang WenXuehan WuYutao QueYuru MaYunzhu WuQuanmeng LiuWenjie FanShen-Ping YuPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
The ESGAR criterion demonstrated moderate diagnostic performance in identifying malignant LNs in patients with rectal cancer after neoadjuvant therapy. It was effective in determining the status of LNs < 5 mm but not for LNs ≥ 5 mm, and the diagnostic efficiency could not be improved by considering nodal morphological characteristics.